Dr. Jason Bates Fleming, MD

Dr. Fleming practices at Plastic Surgery Clinic at UT Southwestern Medical Center - HOPD in Dallas, Texas.

Dr. Fleming's NPI, 1891750618, was assigned on April 18, 2006. Dr. Fleming graduated from University of Tennessee Health Science Center College of Medicine - Memphis in 1990. Dr. Fleming's Florida license number on file is ME133176.

Dr. Fleming's primary practice is Plastic Surgery Clinic at UT Southwestern Medical Center - HOPD, at 1801 Inwood Rd, Dallas, TX 75235.

Dr. Fleming's primary practice is Plastic Surgery Clinic at UT Southwestern Medical Center - HOPD in Dallas, Texas. Dr. Fleming is also affiliated with William P. Clements Jr. University Hospital. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Fleming to 1 more group practice or clinic, named with a free account. Dr. Fleming's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fleming practices, 3 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Fleming's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Fleming is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Fleming's licenses on file in 3 states: Florida, Hawaii and Texas.

CMS data shows 41 Medicare services from Dr. Fleming across 3 procedure codes in 2018, all of them office visits. Medicare paid $4,288 for them. Every service was in a facility, such as a hospital, rather than an office.

Across all payers, Dmand AI patient panel data puts Dr. Fleming's median patient age at 65, with 73% women.

In 2017, Dr. Fleming wrote 11 Medicare Part D claims. They cover 1 drug, with $46,725 in total drug cost. In 2016, CMS named 84 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Fleming for performance year 2024, reported as part of a group. Dr. Fleming accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fleming as offering telehealth.

Dmand AI links 239 papers to Dr. Fleming, published from 2001 to 2025. 2021 was the busiest year, with 15. The most frequent topics are Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal and Adenocarcinoma. Dr. Fleming has published most often in Ann Surg Oncol. Dr. Fleming's most frequent co-authors are Jason B. Fleming, MD, Matthew Harold Katz, MD and Jeffrey E. Lee, MD.

Dmand AI links Dr. Fleming to 2 clinical trials. Conditions studied include Pancreatic Neoplasms and Pancreatic Diseases. M.D. Anderson Cancer Center sponsors the most, 2.

CMS Open Payments shows 26 general payments to Dr. Fleming from 6 drug and device companies from 2016 to 2024. Speaker and faculty fees make up the largest share, 88% of the total. Medtronic, Inc. paid the most, $13,740.

Dmand AI lists 2 awards for Dr. Fleming.

Dr. Fleming graduated from University of Tennessee Health Science Center College of Medicine - Memphis in 1990. Dr. Fleming is a member of ACS and ASCO.

Dr. Fleming is in network with 21 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.